The GENE2SKIN project has received funding from the European Union's Horizon 2020 Research and Innovation programme, under the Grant Agreement Number 692221.
A M-ERA-NET project was awarded to a consortium including Gene2skin members RCSI and UMINHO together with the company IZERTIS. The project will focus on devising a bioprinting strategy to improve skin healing by targeting the wound biomechanic and associated signalling pathways.
The GENE2SKIN project has received funding from the European Union's Horizon 2020 Research and Innovation programme, under the Grant Agreement Number 692221. This website reflects only the author's view and the Commission is not responsible for any use that may be made of the information it contains.